164 results on '"Wieland-Alter, Wendy"'
Search Results
2. Mucosal immunity to poliovirus
3. Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
4. Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States.
5. Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America
6. Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules : Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
7. SPME-GC×GC-TOF MS fingerprint of virally-infected cell culture: Sample preparation optimization and data processing evaluation
8. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
9. Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2
10. Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD Antibodies
11. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
12. Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge
13. A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals
14. Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination
15. Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Protein Triggering Enhances HIV-Specific CD4⁺ T Cell Cytokine Secretion and Protects HIV-Specific CD4⁺ T Cells from Apoptosis
16. Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
17. Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
18. Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection
19. Author response: Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
20. Specificity of the Tuberculin Skin Test and the T-SPOT.'TB' Assay among Students in a Low-Tuberculosis Incidence Setting
21. Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
22. Clinical Coxsackievirus B Isolates Differ from Laboratory Strains in Their Interaction with Two Cell Surface Receptors
23. Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
24. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
25. Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium.
26. Human Seminal Plasma Fosters CD4+ Regulatory T-cell Phenotype and Transforming Growth Factor-β1 Expression
27. Prolonged evolution of the human B cell response to SARS-CoV-2 infection
28. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
29. Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium
30. DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial
31. SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
32. Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
33. A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
34. Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
35. CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial
36. Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania
37. Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments
38. A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.
39. Volatile fingerprinting of human respiratory viruses from cell culture
40. The volatile molecule signature of four mycobacteria species
41. A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa
42. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901
43. Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
44. HSV oropharyngeal shedding among HIV-infected children in Tanzania
45. Molecular Epidemiology of HIV-Associated Tuberculosis in Dar es Salaam, Tanzania: Strain Predominance, Clustering, and Polyclonal Disease
46. Specificity of the Tuberculin Skin Test and the T-SPOT.TBAssay Among Students in a Low–Tuberculosis Incidence Setting
47. Semen Protects CD4+ Target Cells from HIV Infection but Promotes the Preferential Transmission of R5 Tropic HIV
48. Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania
49. Glucocorticoid‐Induced Tumor Necrosis Factor Receptor Family–Related Protein Triggering Enhances HIV‐Specific CD4+T Cell Cytokine Secretion and Protects HIV‐Specific CD4+T Cells from Apoptosis
50. HSV oropharyngeal shedding among HIV-infected children in Tanzania.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.